The past year was challenged with a new administration that was both unpredictable and unconventional, a new FDA commissioner, and high levels of scrutiny surrounding drug prices and opioid useOriginal Article
You may also like
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.